ROBO1 and neoplasm: Recent studies have indicated the possible anticancer attributes of SLIT2-ROBO1 signalling18 pathway in tumour cell migration and angiogenesis in lung cancer19, breast cancer20, gastric cancer21, and colorectal cancer22.